In burn patients, plasma gelsolin levels decreased with increasing burn sizes, and increasing incidence of septic complication, and correlated with development of multiple organ dysfunction syndrome and enhanced burn- and sepsis-associated mortality [47,48]. The gene discussed is GSN; the disease is Sepsis.